Psychological therapies may lead to short-term benefits in quality of life for patients with inflammatory bowel disease (IBD), but the same cannot be said for disease activity, results from a systematic review and meta-analysis suggested.
Looking at data from randomized controlled trials (RCTs) published from 2016 to 2023, psychological therapy led to improvements in quality-of-life scores versus control treatment among patients with active IBD in four RCTs at therapy completion (standardized mean difference [SMD] 0.68, 95% CI 0.09-1.26), though no benefit was noted for anxiety scores in two RCTs (SMD -1.04, 95% CI -2.46 to 0.39).